Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.

Abstract

Here we summarize data on hematopoietic stem cell transplantation (HSCT) to treat severe, refractory, hematologic autoimmune cytopenia. In the last 10 years, limited experience has been gained with the use of HSCT for hematologic disease. A phase II study by the NIH has presented data on autologous HSCT in 14 patients with immune thrombocytopenia (ITP) or… (More)
DOI: 10.1080/08916930802198436

Topics

  • Presentations referencing similar topics